Ranbaxy Costs US Taxpayers $900m on Import Ban

Cheap copies of Novartis AG's heart drug Diovan, on which Ranbaxy has exclusive rights, is not available in market for 18 months



via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/1m5Yjvq April 15, 2014 at 03:04PM http://ift.tt/eA8V8J